Mesoporous silicon nanotechnology for cancer application

Oncologie

Volumn 11, Issue SUPP.1, 2009, Pages

  Bouamrani, A ^a   Serda, R E ^a   Ferrari, M ^a,b,c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Rice University   (United States)

Author keywords

Drug delivery; Personalizedmedicine; Proteomics; Silicon

Indexed keywords

EID: 84893342577     PISSN: 12923818     EISSN: 17652839     Source Type: Journal    
DOI: 10.1007/s10269-009-1111-8     Document Type: Review

References (24)

1. Brown PO, Hartwell L (1998) Genomics and human disease-variations on variation. Nat Genet 18: 91-3.
2. Hartwell L, Mankoff D, Paulovich A, Ramsey S, Swisher E (2006) Cancer biomarkers: a systems approach. Nat Biotechnol 24: 905-8. (Pubitemid 44215377)
3. Baselga J, Norton L, Albanell J, Kim YM, Mendelsohn J (1998) Recombinant humanized anti-her2 antibody (herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against her2/neu overexpressing human breast cancer xenografts. Cancer Res 58: 2825-31. (Pubitemid 28311914)
4. Ward HW (1973) Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels. Br Med J 1: 13-4.
5. Plourde PV, Dyroff M, Dukes M (1994) Arimidex: a potent and selective fourth-generation aromatase inhibitor. Breast Cancer Res Treat 30: 103-11. (Pubitemid 24250763)
6. Tasciotti E, Liu X, Bhavane R, Plant K, et al. (2008) Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol 3: 151-7. (Pubitemid 351355132)
7. Serda RE, Gu J, Bhavane RC, et al. (2009) The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. Biomaterials 30: 2440-8.
8. Chiappini C, Fakhoury JR, Fine D, Pullan L, Wang Y, Fu L, Ferrari M (2009) Tailored porous silicon microparticles for the delivery of nanoparticles (submitted).
9. Decuzzi P, Ferrari M (2008) Design maps for nanoparticles targeting the diseased microvasculature. Biomaterials 29: 377-84. (Pubitemid 350081047)
10. Ruoslahti E (2004) Vascular zip codes in angiogenesis and metastasis. Biochem Soc Trans 32: 397-402.
11. Serda RE, Gu J, Burks JK, Ferrari C, Ferrari K, Ferrari M (2009) Quantitative mechanics of endothelial phagocytosis of silicon microparticles. Cytometry Part A 75A: 752-60.
12. Serda RE, Ferrati S, Godin B, Tasciotti E, Liu X, Ferrari M (2009) Mitotic partitioning of silicon microparticles. Nanoscale (submitted).
13. Serda RE, Mack A, Pulikkathara M, Chiappini C, Zaske AM, Conyers JL, Bankson JA, Liu X, Ferrari M (2009) Cellular association and assembly of a multistage delivery system for magnetic resonance imaging (submitted).
14. Nickoloff JA (1992) Transcription enhances intrachromosomal homologous recombination in mammalian cells. Mol Cell Biol 12: 5311-8.
15. Aebersold R, Mann M (2003) Mass spectrometry-based proteomics. Nature 422: 198-207. (Pubitemid 36362757)
16. Etzioni R, Urban N, Ramsey S, et al. (2003) The case for early detection. Nat Rev Cancer 3: 243-52. (Pubitemid 37328860)
17. Liotta LA, Ferrari M, Petricoin E (2003) Clinical proteomics: written in blood. Nature 425: 905.
18. Anderson NL, Anderson NG (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1: 845-67.
19. Diamandis EP (2004) Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics 3: 367-78.
20. Villanueva J, Philip J, Chaparro CA, et al. (2005) Correcting common errors in identifying cancer-specific serum peptide signatures. J Proteome Res 4: 1060-72. (Pubitemid 41208664)
21. Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5: 161-71.
22. Gaspari M, Cheng MMC, Terracciano R, et al. (2006) Nanoporous surfaces as harvesting agents for mass spectrometric analysis of peptides in human plasma. J Proteome Res 5: 1261-6. (Pubitemid 43727806)
23. Terracciano R, Gaspari M, Testa F, et al. (2006) Selective binding and enrichment for low-molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles. Proteomics 6: 3243-50. (Pubitemid 43886143)
24. Findeisen P, Sismanidis D, Riedl M, Costina V, Neumaier M (2005) Preanalytical impact of sample handling on proteome profiling experiments with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 51: 2409-11. (Pubitemid 41692601)